| Literature DB >> 27773794 |
Min-Wang Zhang1, She-Feng Zhang2, Zhen-Hua Li1, Fang Han3.
Abstract
7,8-Dihydroxyflavone (7,8-DHF) is a naturally-occurring flavone which possesses good bioavailability. Due to its ability to cross the blood-brain barrier, previous studies have demonstrated that 7,8-DHF was a potent tropomyosin-related kinase B (TrkB) agonist, and produced antidepressant-like effects in mouse forced swimming test and tail suspension test. However, it has not been evaluated in chronic mild stress (CMS), a classical depression model modulating the processes of major depression in human. In the present study, we not only evaluated the depressive-like behaviors, but also measured the key proteins of TrkB signaling in mice exposed to CMS. Our results firstly found that long term but not single injection of 7,8-DHF restored the depressive-like behaviors in sucrose preference test and novelty suppressed feeding test. In addition, 7,8-DHF not only increased TrkB phosphorylation and brain-derived neurotrophic factor (BDNF) levels, but also activated the expression of TrkB downstream synaptic proteins such as PSD95 and synaptophysin. Furthermore, the TrkB antagonist K252a blocked the antidepressant-like effects of 7,8-DHF. In summary, the present results demonstrated that chronic 7,8-DHF treatment exerted significant antidepressant-like effects, which were likely attributed to regulating TrkB signaling and thus promoting synaptic protein expression.Entities:
Keywords: 7,8-Dihydroxyflavone (7,8-DHF); Antidepressant-like effects; Chronic mild stress (CMS); PSD95; Synaptophysin; TrkB
Mesh:
Substances:
Year: 2016 PMID: 27773794 DOI: 10.1016/j.neulet.2016.10.035
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046